Cancer Center Support Grant

癌症中心支持补助金

基本信息

批准号：
10244467
负责人：
ROY A. JENSEN
金额：
$ 15.1万
依托单位：
UNIVERSITY OF KANSAS MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2012
资助国家：
美国
起止时间：
2012-07-11 至 2022-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10244467
关键词：
Adoption Advocacy Advocate Agreement American Basic Science Behavior Therapy Biometry Cancer Biology Cancer Burden Cancer Center Cancer Center Support Grant Cancer Control Cancer Research Project Cancer Survivorship Catchment Area Cells Child Cities Clinical Pharmacology Clinical Research Clinical Trials Communication Research Communities Comprehensive Cancer Center Consult Development Diagnosis Education Ensure Environment Fostering Funding Gene Targeting Goals Growth and Development function Health Communication Health Personnel Incidence Informatics Institutes Institution Investigational Therapies Kansas Laboratories Lead Leadership Malignant Neoplasms Medical Research Medical center Modeling Morbidity - disease rate NCI Center for Cancer Research Patients Pharmacotherapy Physicians Population Research Prevention Quality of life Research Personnel Resource Sharing Scientist Therapeutic Training Transgenic Organisms Translational Research Treatment Efficacy Universities Vision Wichita anticancer research base cancer prevention cancer therapy care costs clinical care cost effective drug development drug discovery early phase clinical trial fight against implementation research improved interdisciplinary approach member mortality next generation novel anticancer drug novel therapeutic intervention nutrition pathogen population health precision medicine programs recruit screening survivorship treatment organization

项目摘要

Overall – Project Summary The University of Kansas Cancer Center (KUCC) is a matrix cancer center that includes: the University of Kansas Medical Center campuses in Kansas City, Wichita and Salina, the University of Kansas in Lawrence and via consortium agreement, the Stowers Institute for Medical Research and Children's Mercy Kansas City. In 2015, 187 members of KUCC accounted for $13.4M of NCI funding and a total of $61.2M in overall cancer- related funding, an increase of $10M during the previous funding period. Roy A. Jensen, MD, who is supported by a strong, nationally recognized leadership team, leads KUCC. Over the last four years substantial progress has been made broadening partnerships with communities throughout the KUCC catchment area, boosting recruitment of physician-scientists, augmenting clinical research and early-phase clinical trials, advancing education for the next generation of scientists and health care providers and heightening influence for KUCC researchers in the national scientific community. KUCC has established four specific aims to ensure KUCC leads in the fight against cancer: 1. Leverage unique institutional and regional assets to become a leading academic institution for transforming discoveries from the laboratory into new anticancer drug therapies; 2. Provide the optimal environment to focus the power of precision medicine, basic science inquiry, drug discovery and development, and behavioral interventions to decrease cancer incidence, morbidity and mortality; 3. Be a nationally recognized leader in partnering with key stakeholders, community advocates and regional leaders to develop, promote, and foster the adoption and implementation of research-based cancer prevention, diagnosis, treatment, control, and survivorship practices throughout the KUCC catchment area to mitigate the impact of cancer; and 4. Provide leadership in envisioning, developing and implementing a thoughtful, comprehensive strategy to educate the next generation of physician-scientists and allied investigators in cancer research, treatment, prevention and control. To accomplish these goals KUCC has four research programs: Cancer Biology, Cancer Control and Population Health, Cancer Prevention and Survivorship, and Drug Discovery, Delivery and Experimental Therapeutics. In addition, KUCC supports the Clinical Trials Office, five established shared resources - Biospecimen, Biostatistics and Informatics, Clinical Pharmacology, Lead Development and Optimization and Transgenic and Gene-Targeting – along with three developing shared resources – Cell Authentication and Pathogen Screening, Health Communications Research and Nutrition.

总体 – 项目总结堪萨斯大学癌症中心 (KUCC) 是一个矩阵癌症中心，包括：堪萨斯医学中心位于堪萨斯城、威奇托和萨利纳的校区，堪萨斯大学劳伦斯分校并通过财团协议，斯托尔斯医学研究所和堪萨斯城儿童慈善中心。 2015 年，KUCC 的 187 名成员获得了 NCI 资助 1,340 万美元，总体癌症资助总额为 6,120 万美元。相关资金，在上一个资助期间增加了 1000 万美元，Roy A. Jensen 博士获得了支持。由一个强大的、全国认可的领导团队领导，KUCC 在过去四年中取得了长足的进步。扩大了与整个 KUCC 流域社区的合作伙伴关系，促进了招募医师科学家，加强临床研究和早期临床试验，推进为下一代科学家和医疗保健提供者提供教育并提高 KUCC 的影响力国家科学界的研究人员制定了四个具体目标来确保 KUCC 在抗击癌症方面处于领先地位： 1. 利用独特的机构和区域资产，成为转型领域领先的学术机构实验室发现新的抗癌药物疗法； 2. 提供集中精准医疗、基础科学研究、药物力量的最佳环境发现和开发以及行为干预，以降低癌症发病率、发病率和死亡; 3. 成为与主要利益相关者、社区倡导者和区域合作伙伴合作的全国公认的领导者领导者开发、促进和促进基于研究的癌症的采用和实施整个 KUCC 流域的预防、诊断、治疗、控制和生存实践减轻癌症的影响；以及 4. 领导制定、制定和实施深思熟虑的综合战略教育下一代医师科学家和相关研究人员进行癌症研究、治疗、预防和控制。为了实现这些目标，KUCC 有四个研究项目：癌症生物学、癌症控制和人口健康、癌症预防和生存，以及药物发现、递送和实验治疗。此外，KUCC 支持临床试验办公室、五个已建立的共享资源 - 生物样本、生物统计学和信息学、临床药理学、先导化合物开发和优化以及转基因和基因靶向——以及三个正在开发的共享资源——细胞认证和病原体筛查、健康传播研究和营养。